| twist2 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-106728 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| twist siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-38604 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| twist siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-38605 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| twisted gastrulation siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-72394 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| Recombinant Mouse Twisted Gastrulation (TSG) |
TSG |
50 µg |
756-TG-050 |
R&D SYSTEMS, INC. |
More Info
|
| Recombinant Mouse Twisted Gastrulation (TSG), carrier-free |
TSG |
50 µg |
756-TG-050/CF |
R&D SYSTEMS, INC. |
More Info
|
| TWISTNB siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-154815 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| TWISTNB siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-89350 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| Collagen I, trimer, comprising two a1(I) chains and one a2(I) chain |
Source: Human Placenta. Purity: > 95% by SDS-PAGE |
0.25 mg/0.50 mg |
10-55-2501 |
BIOPUR AG |
More Info
|
| Human Two Chain HMW Kininogen |
n/a |
1.0 mg & 5.0 mg |
2HK 1301 |
ENZYME RESEARCH LABORATORIES INC. |
More Info
|
| BART1 (Binder of Arl Two, Arf-like 2 Binding Protein) Recombinant, Human |
ADP-ribosylation factor (ARF)-like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. This protein binds to ARL2.GTP with high affinity but does not interact with ARL2.GDP, activated ARF, or RHO protei... |
50ug |
B0094-35 |
UNITED STATES BIOLOGICAL |
More Info
|
| TMB Two Component HRP Microwell Substrate |
n/a |
200 ml |
45-053-150021 |
GENWAY BIOTECH INC. |
More Info
|
| TMB Two Component HRP Microwell Substrate |
n/a |
2 l |
45-053-150021 |
GENWAY BIOTECH INC. |
More Info
|
| Two chain tPA, human, recombinant |
n/a |
1 mg |
170 |
AMERICAN DIAGNOSTICA INC. |
More Info
|
| Two chain tPA, human, recombinant, activity standard (stabilized in 1% BSA) |
n/a |
10 ug |
176 |
AMERICAN DIAGNOSTICA INC. |
More Info
|
| Two chain tPA, human, recombinant, protein standard (carrier free) |
n/a |
50 ug |
174 |
AMERICAN DIAGNOSTICA INC. |
More Info
|
| Complement C1r, Human, Activated, Two-Chain Form |
Native, human, activated, C1r complement component. Generally the non-activated form composed of a single-chain glycoprotein. Present in normal human serum at 34 µg/ml. Non-activated C1r is found in circulating blood plasma as a dimer that a... |
n/a |
204878 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| Complement C1s, Human, Activated, Two-Chain Form |
Native, human, activated C1s complement component. Present in human serum at 31 µg/ml. Nonactivated C1s is found in circulating blood plasma as a Ca2+-dependent dimer in association with one C1q molecule and two C1r molecules to form the fir... |
n/a |
204879 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| 11 dehydro thromboxane B2 (11dhTxB2) |
AspirinWorks(R) ELISA Kit to measure levels of 11dhTxB2 in human urine |
96 well |
12136 |
CORGENIX INC. |
More Info
|
| Iberiotoxin (Scorpion, Buthus tamulus) (IbTx) |
Sequence: Pyr-Phe-Thr-Asp-Val-Asp-C ys-Ser-Val-Ser-Lys-Glu-Cy s-Trp-Ser-Val-Cys-Lys-Asp -Leu-Phe-Gly-Val-Asp-Arg- Gly-Lys-Cys-Met-Gly-Lys-L ys-Cys-Arg-Cys-Tyr-GlnSto rage and Stability: Lyophilized powder may be stored at 4?C for short-term only. Recons... |
5mg |
I0450-01 |
UNITED STATES BIOLOGICAL |
More Info
|
| Caspase 4, Active, Recombinant, Human (ICErelII, TX, Ich-2) |
Caspase-4 (also know as ICErelII, TX, Ich-2) is the member of the caspase family of cysteine proteases. Caspase-4 exists in cells as an inactive pro-enzyme. The pro-enzyme is matured by proteolysis to yield large and small subunits. The active enz... |
25u |
C2087-24B |
UNITED STATES BIOLOGICAL |
More Info
|
| Influenza A Antigen strain TX |
Influenza A Antigen strain TX. Influenza A Antigen Strain Texas |
1 ml |
10-511-248157 |
GENWAY BIOTECH INC. |
More Info
|
| Imeratoxin-Inhibitor (IpTx-i) |
n/a |
10 µg. |
TXL8203-10 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Imeratoxin-Inhibitor (IpTx-i) |
n/a |
5x10 µg. |
TXL8203-50 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin-PbTx2 |
n/a |
100 µg. |
TXL8901-100 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin-PbTx2 |
n/a |
5x100 µg. |
TXL8901-500 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin-PbTx3 |
n/a |
100 µg. |
TXL8902-100 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin-PbTx3 |
n/a |
5x100 µg. |
TXL8902-500 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin-PbTx9 |
n/a |
100 µg. |
TXL8903-100 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin-PbTx9 |
n/a |
5x100 µg. |
TXL8903-500 |
ACCURATE CHEMICAL & SCIENTIFIC CO. |
More Info
|
| Brevetoxin PbTx-2, Ptychodiscus brevis |
Lipid-soluble polyether neurotoxin that binds to Na+ channels on nerves and muscles causing an excessive influx of Na+ across membranes. Binds at site 5 on the voltage-sensitive Na+ channel. |
n/a |
203732 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| Brevetoxin PbTx-3, Ptychodiscus brevis |
Lipid-soluble polyether marine toxin produced by the red tide dinoflagellate, Ptychodiscus brevis, found along the Gulf Coast of Florida. Voltage-dependent Na+ channel activator that causes contractile paralysis in animal models by binding to a un... |
n/a |
203734 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| Brevetoxin PbTx-6, Ptychodiscus brevis |
Lipid-soluble polyether marine toxin produced by the red tide dinoflagellate, Ptychodiscus brevis, found along the Gulf Coast of Florida. Voltage-dependent Na+ channel activator that causes contractile paralysis in animal models by binding to a un... |
n/a |
203737 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| TX-1123 |
A cell-permeable arylidene-cyclopentenedio ne derived tyrphostin that acts as an inhibitor for Src, eEF2-K, and PKA (IC50 = 2.2, 3.2, and 9.6 µM, respectively), while it inhibits EGFR-K and PKC at much higher concentrations (IC50 = 320 µ... |
n/a |
655200 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| TX-1918 |
A cell-permeable arylidene-cyclopentenedio ne derived tyrphostin that acts as a potent inhibitor for eEF2-K (IC50 = 440 nM), while it inhibits other kinases at much higher concentrations (IC50 = 4.4, 44, 44, and 440 µM for Src, PKA, PKC, and ... |
n/a |
655203 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| TXA2R siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-154816 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| TXA synthase siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-76779 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| TXA2R siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-40226 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| TXA synthase siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-62451 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| Thromboxane 11-H2 (TXB2) BioAssay ELISA Kit |
11-Dehydro-Thromboxane B2 (11-D-TXB2) is derived from TXB2 by the action of 11-dehydrogenase. It is one of the major metabolites of TXB2 in plasma and urine. Measurement of 11-D-TXB2 in plasma represents an approach to the assessment of thromboxan... |
1Kit |
T5113 |
UNITED STATES BIOLOGICAL |
More Info
|
| Thromboxane B2 (TXB2) BioAssay ELISA Kit |
Thromboxane B2 (TXB2) is a stable hydrolyzed product of unstable TXA2 which is derivedfrom PGH2. PGH2 is synthesized from arachidonic acid through the cyclooxygenase pathway. It is a major product following platelet aggregation induced by a variet... |
1Kit |
T5120-02 |
UNITED STATES BIOLOGICAL |
More Info
|
| 11-dehydro-TXB2 EIA Kit |
Range: 9.8 - 10,000 pg/mL |
1x96 well |
900-092 |
ASSAY DESIGNS INC. |
More Info
|
| 11-dehydro-TXB2 EIA Kit |
Range: 9.8 - 10,000 pg/mL |
5x96 well |
901-092 |
ASSAY DESIGNS INC. |
More Info
|
| TXB2 EIA Kit |
Range: 13.7 - 10,000 pg/mL |
1x96 well |
900-002 |
ASSAY DESIGNS INC. |
More Info
|
| TXB2 EIA Kit |
Range: 13.7 - 10,000 pg/mL |
5x96 well |
901-002 |
ASSAY DESIGNS INC. |
More Info
|
| TXB2 Singleplex MultiBead Kit |
Range: 13.7 - 10,000 pg/mL |
1 x 96 well |
985-007 |
ASSAY DESIGNS INC. |
More Info
|
| TXK, active kinase (Recombinant Human) |
n/a |
1ug, 5ug, 10ug, 20ug |
T19-11G |
SIGNALCHEM |
More Info
|
| Txk siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-38943 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| Txk siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-38944 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| Txl-2 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-78475 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|